Notice of Proposed Sale · 144
Oruka Therapeutics, Inc.
ORKANASDAQEQUITYCurrent
Notice of Proposed Sale
Company context
Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from inflammatory diseases like plaque psoriasis and hidradenitis suppurativa the greatest possible freedom from their condition by achieving high rates of disease clearance with dosing as infrequently as once or twice a year. For more information, visit www.orukatx.com and follow Oruka on LinkedIn.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗